Advertisement

Topics

Companies Related to "SeborrheaGlobal Manufacturers Marketed Phase Drugs Landscape 2017 Updated" [Most Relevant Company Matches] - Page: 3 RSS

18:00 EST 17th February 2019 | BioPortfolio

Here are the most relevant search results for "SeborrheaGlobal Manufacturers Marketed Phase Drugs Landscape 2017 Updated" found in our extensive corporate database of over 50,000 company records.

Showing "SeborrheaGlobal Manufacturers Marketed Phase Drugs Landscape 2017 Updated" Companies 51–75 of 3,700+

Relevant

EvaluatePharm

EvaluatePharma® – helping you to analyse the past and future performance of the pharmaceutical and biotechnology business sector.EvaluatePharma® provides comprehensive coverage of more than 400 companies and over 11,000 products from early stage R&D through to Marketed and beyond, tracking the past and future performance of the pharma and biotech business sectors.Historic sales (since 1986), c...


Phase One Medical

Phase One Medical is a privately held medical device research and development company. The company is focused on early stage device development and small part design and manufacture. For more information on Phase One Medical, L.L.C. products and services e-mail the company at info@phase-one.us or visit the company’s web site at: www.phaseonemedical.co...

Topigen Pharmaceuticals Inc.

TOPIGEN is developing several new classes of drugs and is actively progressing two drug candidates in Phase II trials for COPD and asthma. These drugs are uniquely focused on inhibiting multiple inflammation targets underlying the chronic pulmonary diseases. TOPIGEN also has a number of discovery research programs focused on the identification of novel compounds for the treatment of COPD and aller...


Modra Pharmaceuticals

Modra Pharmaceuticals is contributing to modern cancer treatment options by improving the delivery and bioavailability of chemotherapy, the backbone of oncology regimens today. Through our oral formulation technology, we can bypass limitations of IV-delivered drugs, enabling a better product for patients. Our pipeline includes two of the most broadly used ...

Probably Relevant

Central Rexall Drugs, Inc

At Central Rexall Drugs, Inc. we try to do the utmost to treat you the way we like to be treated. Our pharmacists have earned a reputation for professionalism and genuine concern for our customers.Three generations of the Fellows family have owned and operated Central Rexall Drugs. Central Rexall Drugs has provided more than 107 years of quality service to the Hammond community. Central Rexall D...

Ratiopharm

On June 29, 2000, ratiopharm GmbH, Europe's largest generic drug company, purchased Technilab Pharma to establish ratiopharm's generic operations in Canada. Long before being acquired by ratiopharm GmbH, Technilab Pharma and its group of companies, enjoyed a rich history and played an important role in the evolution of the Canadian generic industry.Founded in 1974, with head office in Mirabel, Que...

Kamada, Ltd.

Kamada is a public biopharmaceutical company (TASE: KMDA) developing, producing and marketing a line of specialty life-saving biopharmaceuticals. Licensed and marketed worldwide, several of these specialty therapeutics are currently undergoing advanced clinical trials. Kamada is currently in the process of conducting a clinical trial with its second genera...

MonoSol Rx, LLC

MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm® technology to deliver drugs in films. PharmFilm® is designed to benefit patients by improving the convenience, efficacy, and compliance of new and currently marketed drugs. The Company's leadership in film drug delivery is supported by strong intellectual property, a portfolio of commercialized prescription an...

BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc.

BioSante’s corporate strategy is to develop high value medically-needed pharmaceutical products and to implement strategic alternatives with respect to its products and its company, including licenses, business collaborations and other business combinations or transactions with other pharmaceutical and biotechnology companies. BioSante’s products ...

Ventaira

Ventaira is an emerging specialty pharmaceutical company focused on developing pharmaceutical products for inhalation by utilizing its' novel proprietary electrohydrodynamic (EHD) aerosolization technology and formulation technologies to improve the profile of new or existing drugs. The device and technology lends itself to a range of drugs that can be formulated with parameters that are optimum f...

Salix Pharmaceuticals, Inc.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, NC, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix’s strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete with any required development and regulatory submission of these products, and market them ...

Pro-Pharmaceuticals

Pro-Pharmaceuticals Inc. is a research leader in developing a new generation of Glyco-upgrade™ oncologic drugs. We target sugar-specific binding sites found on cancer cells using carbohydrate technology with the goal of improving efficacy and reducing toxicity of some of the proven, commonly used anti-cancer drugs.Two platforms of technologies have been identified by Pro- Pharmaceuticals. The fi...

Acusphere, Inc.™

Acusphere, Inc.™ is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary porous microsphere technology. We are focused on developing proprietary drugs that can offer significant benefits such as improved safety and efficacy, increased patient compliance, greater ease of use, expanded indications or reduced cost. Our three in...

DOV Pharmaceutical

We are a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, cardiovascular and urological disorders. We have five product candidates in clinical trials addressing therapeutic indications with significant unmet needs. Our product candidate for insomnia is currently in Phase III clinical trials and o...

Weston Medical Group plc

Weston Medical Group plc is an innovative drug delivery company which aims to meet the needs of patients, pharmaceutical companies and healthcare professionals by providing innovative, cost-effective and user-friendly drug delivery systems. Weston Medical (WMG.L) is listed on the London Stock Exchange. Its shares are classified in the Pharmaceuticals Sector and it is also included on techMARK. The...

Update Pharma Inc.

Update Pharma Inc. is developing UPI-928, an agent developed in the 1980’s by Lederle Laboratories in 44 phase 1, 2 and 3 clinical trials, including 33 clinical trials at the National Cancer Institute. Despite an acceptable safety database of over 2,000 treated patients, over 70 peer reviewed clinical publications that demonstrated efficacy in leukemi...

DeveloGen

DeveloGen is a biopharmaceutical company engaged in the discovery and development of novel therapeutic drugs for the treatment of metabolic disorders. The Company has a broad and innovative pipeline from lead discovery to phase III clinical development.

Forest Laboratories

Forest Laboratories develops, manufactures and sells both branded and generic forms of ethical products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter, which are used for the treatment of a wide range of illnesses. Forest products are marketed principally in the United States and western and eastern Europe. Marketing is conducte...

Italfarmaco

Italfarmaco is a specialty pharmaceutical company engaged in the discovery, development, manufacturing and marketing of branded prescription and nonprescription products in more than 60 countries on 5 continents. Italfarmaco’s research and development expertise is best demonstrated through its HDAC inhibitor development programs, some of which are foc...

Emergent BioSolutions

Emergent BioSolutions Inc. is a biopharmaceutical company dedicated to one simple mission—to protect life. We develop, manufacture and commercialize immunobiotics, consisting of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Our biodefense business focuses on immunobiotics for use against biological agents that are potential weapons of bioterroris...

Scios Incorporated

Scios Inc. is a biopharmaceutical company engaged in the discovery, development, manufacture and commercialization of novel human therapeutics based upon its capabilities in both protein-based and small-molecule drug discovery and development. An NDA for the use of Natrecor(R) (nesiritide) for the short-term management of congestive heart failure ispending with the U.S. Food an...

Celltrion Inc.

Headquartered in Incheon, Korea, Celltrion is a leading biopharmaceutical company, specializing in research, development and manufacture of biosimilar and innovative drugs. Celltrion strives to provide more affordable biosimilar mAbs to patients who previously had limited access to advanced therapeutics. Celltrion received FDA and EMA approval for Inflectr...

Zalicus Inc

Zalicus focuses its internal drug development efforts on pain and immuno-inflammatory diseases. Our pipeline for pain includes Exalgo™ (hydromorphone HCl) extended-release tablets (marketed by Covidien), for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended per...

OLIVE OIL KANSAI 2017

Penfolds

Penfolds has been producing an impressive array of wines since 1844 and arguably led the development of Australian fine wine into the modern era. The introduction of Penfolds Grange in 1951 forever changed the landscape of Australian fine wine. Since then a series of stand-out wines, both white and red, have been released under the Penfolds masthead. The 1990s was a period of intense winemaking ...


More From BioPortfolio on "SeborrheaGlobal Manufacturers Marketed Phase Drugs Landscape 2017 Updated"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks